6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure

Hypertrophic stress-induced cardiac remodeling is a compensatory mechanism associated with cardiomyocyte hypertrophy and cardiac fibrosis. Continuation of this response eventually leads to heart failure. The histone acetyltransferase p300 plays an important role in the development of heart failure,...

Full description

Bibliographic Details
Main Authors: Yuto Kawase, Yoichi Sunagawa, Kana Shimizu, Masafumi Funamoto, Toshihide Hamabe-Horiike, Yasufumi Katanasaka, Satoshi Shimizu, Philip Hawke, Kiyoshi Mori, Maki Komiyama, Koji Hasegawa, Tatsuya Morimoto
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Nutrients
Subjects:
Online Access:https://www.mdpi.com/2072-6643/15/9/2232
_version_ 1797601917157769216
author Yuto Kawase
Yoichi Sunagawa
Kana Shimizu
Masafumi Funamoto
Toshihide Hamabe-Horiike
Yasufumi Katanasaka
Satoshi Shimizu
Philip Hawke
Kiyoshi Mori
Maki Komiyama
Koji Hasegawa
Tatsuya Morimoto
author_facet Yuto Kawase
Yoichi Sunagawa
Kana Shimizu
Masafumi Funamoto
Toshihide Hamabe-Horiike
Yasufumi Katanasaka
Satoshi Shimizu
Philip Hawke
Kiyoshi Mori
Maki Komiyama
Koji Hasegawa
Tatsuya Morimoto
author_sort Yuto Kawase
collection DOAJ
description Hypertrophic stress-induced cardiac remodeling is a compensatory mechanism associated with cardiomyocyte hypertrophy and cardiac fibrosis. Continuation of this response eventually leads to heart failure. The histone acetyltransferase p300 plays an important role in the development of heart failure, and may be a target for heart failure therapy. The phenolic phytochemical 6-shogaol, a pungent component of raw ginger, has various bioactive effects; however, its effect on cardiovascular diseases has not been investigated. One micromolar of 6-shogaol suppressed phenylephrine (PE)-induced increases in cardiomyocyte hypertrophy in rat primary cultured cardiomyocytes. In rat primary cultured cardiac fibroblasts, 6-shogaol suppressed transforming growth factor-beta (TGF-β)-induced increases in L-proline incorporation. It also blocked PE- and TGF-β-induced increases in histone H3K9 acetylation in the same cells and in vitro. An in vitro p300-HAT assay revealed that 6-shogaol suppressed histone acetylation. The mice underwent transverse aortic constriction (TAC) surgery, and were administered 0.2 or 1 mg/kg of 6-shogaol daily for 8 weeks. 6-shogaol prevented TAC-induced systolic dysfunction and cardiac hypertrophy in a dose-dependent manner. Furthermore, it also significantly inhibited TAC-induced increases in histone H3K9 acetylation. These results suggest that 6-shogaol may ameliorate heart failure through a variety of mechanisms, including the inhibition of p300-HAT activity.
first_indexed 2024-03-11T04:09:58Z
format Article
id doaj.art-49f78a98a8964548a97db7ff370fbae8
institution Directory Open Access Journal
issn 2072-6643
language English
last_indexed 2024-03-11T04:09:58Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Nutrients
spelling doaj.art-49f78a98a8964548a97db7ff370fbae82023-11-17T23:30:56ZengMDPI AGNutrients2072-66432023-05-01159223210.3390/nu150922326-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart FailureYuto Kawase0Yoichi Sunagawa1Kana Shimizu2Masafumi Funamoto3Toshihide Hamabe-Horiike4Yasufumi Katanasaka5Satoshi Shimizu6Philip Hawke7Kiyoshi Mori8Maki Komiyama9Koji Hasegawa10Tatsuya Morimoto11Division of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanLaboratory of Scientific English, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Translational Research, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanDivision of Molecular Medicine, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka 422-8526, JapanHypertrophic stress-induced cardiac remodeling is a compensatory mechanism associated with cardiomyocyte hypertrophy and cardiac fibrosis. Continuation of this response eventually leads to heart failure. The histone acetyltransferase p300 plays an important role in the development of heart failure, and may be a target for heart failure therapy. The phenolic phytochemical 6-shogaol, a pungent component of raw ginger, has various bioactive effects; however, its effect on cardiovascular diseases has not been investigated. One micromolar of 6-shogaol suppressed phenylephrine (PE)-induced increases in cardiomyocyte hypertrophy in rat primary cultured cardiomyocytes. In rat primary cultured cardiac fibroblasts, 6-shogaol suppressed transforming growth factor-beta (TGF-β)-induced increases in L-proline incorporation. It also blocked PE- and TGF-β-induced increases in histone H3K9 acetylation in the same cells and in vitro. An in vitro p300-HAT assay revealed that 6-shogaol suppressed histone acetylation. The mice underwent transverse aortic constriction (TAC) surgery, and were administered 0.2 or 1 mg/kg of 6-shogaol daily for 8 weeks. 6-shogaol prevented TAC-induced systolic dysfunction and cardiac hypertrophy in a dose-dependent manner. Furthermore, it also significantly inhibited TAC-induced increases in histone H3K9 acetylation. These results suggest that 6-shogaol may ameliorate heart failure through a variety of mechanisms, including the inhibition of p300-HAT activity.https://www.mdpi.com/2072-6643/15/9/22326-shogaolp300histone acetyltransferasecardiac remodelingheart failure
spellingShingle Yuto Kawase
Yoichi Sunagawa
Kana Shimizu
Masafumi Funamoto
Toshihide Hamabe-Horiike
Yasufumi Katanasaka
Satoshi Shimizu
Philip Hawke
Kiyoshi Mori
Maki Komiyama
Koji Hasegawa
Tatsuya Morimoto
6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
Nutrients
6-shogaol
p300
histone acetyltransferase
cardiac remodeling
heart failure
title 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
title_full 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
title_fullStr 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
title_full_unstemmed 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
title_short 6-Shogaol, an Active Component of Ginger, Inhibits p300 Histone Acetyltransferase Activity and Attenuates the Development of Pressure-Overload-Induced Heart Failure
title_sort 6 shogaol an active component of ginger inhibits p300 histone acetyltransferase activity and attenuates the development of pressure overload induced heart failure
topic 6-shogaol
p300
histone acetyltransferase
cardiac remodeling
heart failure
url https://www.mdpi.com/2072-6643/15/9/2232
work_keys_str_mv AT yutokawase 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT yoichisunagawa 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT kanashimizu 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT masafumifunamoto 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT toshihidehamabehoriike 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT yasufumikatanasaka 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT satoshishimizu 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT philiphawke 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT kiyoshimori 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT makikomiyama 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT kojihasegawa 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure
AT tatsuyamorimoto 6shogaolanactivecomponentofgingerinhibitsp300histoneacetyltransferaseactivityandattenuatesthedevelopmentofpressureoverloadinducedheartfailure